Porous Silicon Microparticles Enable Sustained Release of GLP-1R Agonist Peptides for the Treatment of Type 2 Diabetes

Search results

• Active

  ARC Industrial Transformation Training Centre for Cryo-Electron Microscopy of Membrane Proteins for Drug Discovery

  Sexton, P. (Primary Chief Investigator (PCI)), Rouiller, I. (Chief Investigator (CI)), Wootten, D. (Chief Investigator (CI)), van Oijen, A. (Chief Investigator (CI)), Parker, M. W. (Chief Investigator (CI)), Lucet, I. (Partner Investigator (PI)), Griffin, M. D. W. (Chief Investigator (CI)), Adams, D. J. (Chief Investigator (CI)), Czabotar, P. E. (Partner Investigator (PI)), Flocco, M. (Partner Investigator (PI)), Shepherd, R. K. (Partner Investigator (PI)), Ciferri, C. (Partner Investigator (PI)), Williams, P. A. (Partner Investigator (PI)), Brown, D. (Partner Investigator (PI)), Schreuder, H. (Partner Investigator (PI)), Reedtz-Runge, S. (Partner Investigator (PI)), Drinkwater, C. (Partner Investigator (PI)), Howard, B. L. (Partner Investigator (PI)), Betigeri, G. (Partner Investigator (PI)), Pryor, E. (Partner Investigator (PI)), How, J. (Project Manager), Pierce, T. (Chief Investigator (CI)) & Lees, J. (Partner Investigator (PI))

  Boehringer Ingelheim (Germany), AstraZeneca (United Kingdom)

  23/03/21 → 23/03/27

  Project: Research

• Finished

  NHMRC Research Fellowship

  Sexton, P. (Primary Chief Investigator (PCI))

  1/01/19 → 31/12/23

  Project: Research

• Novel targeting of the glucagon family of G protein coupled receptors

  Wootten, D. (Primary Chief Investigator (PCI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/19 → 31/12/23

  Project: Research